"The pharma industry is growing by 14 per cent every year. With relaxed FDI norms, I think pharma sector will grow by 20 per cent," Kumar s...

Until now to buy into an Indian enterprise, multinational drug companies needed an approval from FIPB under department of industrial policy...

The government today allowed up to 74 per cent foreign direct investment in the existing pharmaceutical companies through automatic route.

According to a proposal, FDI up to 49% should be allowed through the automatic route and anything beyond through approval of the FIPB, sour...

The experts would look into the impact of foreign direct investment in the brownfield pharmaceutical companies and access to affordable med...

The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies

"The government’s intention is to harmonise concept of cumulative foreign investment in a company and this will bring more clarity."

The Union Cabinet has rejected a proposal to limit foreign direct investment in domestic manufacturers of “rare and critical” drugs.

Currently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment Promotion Board (FIPB).

The proposal of the DIPP, seeks to restrict FDI in brownfield pharma units, an official familiar with the matter said.

Non-compete clauses restrict the promoters of target companies from venturing into the same line of business for a certain numbers of years.

US-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...

DIPP backed by the health min, may pitch for barring foreign direct investment in existing rare and critical domestic drug making facilitie...

The market share of foreign companies in the list of top 10 pharma companies in India rose from 10.5 per cent in 2004-05 to almost 19 per c...

Chidambaram today said the government will soon finalise the foreign investment policy on brownfield pharmaceutical projects.

Commerce Minister Anand Sharma has urged Prime Minister Manmohan Singh to convene a high-level review meeting to deliberate on the matter.

DIPP may consider allowing foreign direct investment of up to 49 per cent through automatic route in existing Indian pharmaceutical firms.